Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.50p -1.50% 32.75p 96,006 09:34:13
Bid Price Offer Price High Price Low Price Open Price
32.00p 33.50p 33.25p 32.75p 33.25p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.4 -4.8 -3.2 - 39.53

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
15/6/201811:22FUTURA a winner for 20154,284
21/3/201809:19www.bluediamondcondom.com56
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414
21/6/201608:43fum reality1
07/11/201412:19fum-

Add a New Thread

Futura Medical (FUM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

DateSubject
17/6/2018
09:20
Futura Medical Daily Update: Futura Medical is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 33.25p.
Futura Medical has a 4 week average price of 30.75p and a 12 week average price of 30.75p.
The 1 year high share price is 57p while the 1 year low share price is currently 21.50p.
There are currently 120,696,002 shares in issue and the average daily traded volume is 262,583 shares. The market capitalisation of Futura Medical is £39,527,940.66.
05/6/2018
10:12
martinelwick: Good morning,I will not be able to attend the forthcoming AGM,but would like you to please address my following concerns,at the meeting.1.Why do think, given the potential for the ED treatment,that you keep stating,the share price is only 37p as I write.2.You have had two institutional investor presentations in the last couple of years,but failed to attract a single new investor.Why do you think this is?.Is it the product,the business model,or little faith in your management team to deliver,or perhaps a combination of all three.3.Why over the 10 years that I have been invested in FUM you have lost 4 license Partnerships4. Who was responsible for the 2 year shelf life debacle.This must surly have been a factor in the return of the last license.5. Why are we still waiting for regulatory approval re the shelf life?6.Why are we not selling in Holland and Belgium any longer.7 Why do we have complete radio silence concerning the pain relief portfolio.8.why has FUM consistently failed to meet promised timelines e.g. med 2002 deal by end of 2017.Its now June 2018.9.Do you concede that ,yes you have some very good potential products,but due to miss management we are still years away from any meaningful commercial achievement.Yours Martin Elwick.
10/5/2018
10:01
rrr: toadhall, People have been saying that here for years. One day it may come true. Meanwhile, some people, including myself, understandably use this board to express their frustrations at serial failures to deliver, and serious setbacks. Before anyone complains that myself and others are doing down our own company, yes it's true we're being critical - but not without reason - but there's no harm in letting off steam, I'm sure what a handful of people say here has no bearing on the share price. For that to rise we need sustained good news with money attached. In the other direction, people write as you did, encouragingly. It was said here four or five weeks ago by someone that the share price would be 'in the stratosphere' quite soon (if I recall correctly). No harm done, but saying it hasn't made it happen either. rrr
06/4/2018
15:32
lbo: The share price was falling this morning since before the AGM announcement. If Mr Barder does not come good on his most recent promises before the AGM and get the share price back above the last placing price then his tenure like the share price should should also be falling at the AGM.
02/3/2018
15:12
j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here.
14/2/2018
18:00
wi1l: Mike, the buying stopped about 10.30. If he has that effect on the share price every day he's welcome! Not much selling either today, maybe the seller has slowed or waiting for a better price. There's a lot of discussion re the lack of news - I do hope it will be worth the wait and holding on but I have a good feeling about this share now especially at such a low price. Everyone holding with few shares available will see the share price rocket if that buyer persists IMHO can only be good can't it??
02/1/2018
16:24
loobrush: from iii Back to 55p soon in my view-then upward Why is Futura share price rising. It seems to me that most have forgotten that Futura was around 55p when Church and Dwight decided to relinquish their CSD500 licences for a large part of Europe and the USA and that caused the drop from 55p to recent low of 25p. Whilst this was dissapointing news then, it may well turn out to a real Bonus as Church & Dwight were going nowhere with it. Those licences are now looking for a home and there could be a number of companies who are very interested in acquiring them. The recent share price increase could well be that a new deal for the licences is in the offing and if so, a share price rise back to 55pfor a start. Futura has already stated that it expects a deal to be signed around end March for their MED 2000 and if a deal is announced on these US and Europe licenses for CSD500 then Futura's share price may well reach a new high in the 90p plus area. Just a thought, maybe someone will take up CSD500 and Med 2000 for over the counter use-would be a good combination. Or maybe it all goes to a company selling online. Lets see
28/9/2017
13:31
loobrush: Price has certainly tanked since jump to 85p back in last year showing how sensitive share price is to good and bad news. The last bit of bad news from Church & Dwight has caused this latest drop to todays price. Is this the bottom? Last time the price dipped to 15p for a few days but this time may not go this low. However we must be near a low point and any good news will shift the share price much higher very quickly. Should any sort of deal be announced on Med2000, which in my view should be this year,then we may get back to the 85p high as a lot of uncertainty will be removed. If all the products showed progress the potential is still with a share price going well into the £1.00's bet its a gamble. Company value currently only £26 million with £10 million in the bank. So with all that have decided to buy some more today at a much cheaper price than I bought before as I think we are very near if not at a low point with a bounce due on news which could come at any time..
07/6/2017
09:33
mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4
06/6/2017
22:59
jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here.
27/3/2017
11:41
loobrush: from iii What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentation (which not many may have seen-but now available on their website) what news Futura expects to announce during 2017, of which there is quite a lot. MED2000-Securing of major commercial deal. CSD500-Church & Dwight launch in selected markets(probably UK, France & Germany ) CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the £25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following peak potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= £800 million say @5% royalty is £40 million pa TPR100 & TIB200 (1/2 billion per annum)=£400 million say @5% royalty is £20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=£450 million @ 5% royalty rate is £9 million per annum. That totals to £69 million per annum. That's the peak potential. Lets discount that by 1/2 that gives £34.5 million per annum. So with an income of that size with minimal overheads the company on a p/e of 8 would be valued at £552 million or 460p per share Current company value@53p is £63million So the potential is 9 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and big bucks coming after the MED 2000 trial results in a year or so. Price may drift a bit before the first news but as news may come at any time so it's a hold or buy at this price in my view. Also there may be a surprise announcement of a new product(s) as they are working on this at the moment.
Futura Medical share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20180618 03:26:19